glp-1 agonists for type 2 diabetes receptor are increasingly used to treat and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read Potential renoprotective effects of GLP1

Challenges and Limitations Research and Evidence Limitations Multiple challenges continue to constrain the current understanding of the therapeutic potential of BPC-157 and TB-500

Burekovic A., Terzic M., Alajbegovic S., Vukojevic Z., Hadzic N

Glutathione helps boost our liver function

The ELA-32 peptide, a mature form of elabela, alleviates neuronal ferroptosis, reduces cerebral infarction volume, and improves neurobehavioral deficits and cognitive dysfunction

The new aox ferulic formula contains the same active ingredients as always plus two new active ingredients, acting as a powerful synergistic duo: glutathione and astaxanthin

Biliary Copper Excretion Bile is the major physiologic route for eliminating excess copper